mRNA cancer vaccines: Advances, trends and challenges
2022 · Acta Pharmaceutica Sinica B · 145 citations
https://doi.org/10.1016/j.apsb.2022.03.011
J
Junzhi Wang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
446
Papers
8.8K
Citations
48
h-index
149
i10-index
Junzhi Wang is an academic researcher from Shenyang Pharmaceutical University. The author has contributed to research in topics: Viral Infections and Immunology Research & Monoclonal and Polyclonal Antibodies Research & Influenza Virus Research Studies. The author has an h-index of 48, co-authored 380 publications.
ORCID: 0000-0001-6106-1171Papers by this author
worksMolecular mechanism of SCARB2-mediated attachment and uncoating of EV71
2014 · Protein & Cell · 122 citations
https://doi.org/10.1007/s13238-014-0087-3
Whole genome sequencing revealed host adaptation-focused genomic plasticity of pathogenic Leptospira
2016 · Scientific Reports · 118 citations
https://doi.org/10.1038/srep20020
Extracellular vesicle-based drug overview: research landscape, quality control and nonclinical evaluation strategies
2025 · Signal Transduction and Targeted Therapy · 87 citations
https://doi.org/10.1038/s41392-025-02312-w
Hpa1 is a type III translocator in Xanthomonas oryzae pv. oryzae
2018 · BMC Microbiology · 50 citations
https://doi.org/10.1186/s12866-018-1251-3
Immunity and clinical efficacy of an inactivated enterovirus 71 vaccine in healthy Chinese children: a report of further observations
2015 · BMC Medicine · 42 citations
https://doi.org/10.1186/s12916-015-0448-7
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat